Renalytix replaces auditor; EY out, CohnReznick in for FY2024

Renalytix plc

Audit committee dismissed EY effective June 18, 2024; engaged CohnReznick LLP as new auditor for FY ending June 30, 2024.
EY's reports for FY2023, 2022, 2021 had no adverse opinion, except a going-concern explanatory paragraph for FY2023.
No disagreements with EY on accounting principles; past material weakness in stock-based compensation internal control was remediated by June 30, 2023.
Auditor change part of cost-reduction and optimization of third-party support services.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.